News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
80,591 Results
Type
Article (6601)
Company Profile (7)
Press Release (73983)
Section
Business (21764)
Career Advice (395)
Deals (3200)
Drug Delivery (4)
Drug Development (7970)
Employer Resources (41)
FDA (2632)
Job Trends (1748)
News (35495)
Policy (3124)
Tag
Academia (499)
Alliances (6388)
Alzheimer's disease (484)
Approvals (2625)
Artificial intelligence (40)
Bankruptcy (36)
Best Places to Work (1536)
Breast cancer (22)
Cancer (153)
Career advice (333)
Cell therapy (17)
Clinical research (5898)
Collaboration (68)
COVID-19 (455)
C-suite (14)
Data (137)
Diabetes (18)
Diagnostics (1199)
Drug discovery (12)
Earnings (6887)
Employer resources (38)
Events (9481)
Executive appointments (34)
FDA (2717)
Funding (33)
Gene therapy (16)
GLP-1 (95)
Government (501)
Healthcare (2660)
Infectious disease (459)
Inflammatory bowel disease (16)
Interviews (78)
IPO (1155)
Job creations (236)
Job search strategy (268)
Layoffs (63)
Legal (492)
Liver cancer (12)
Lung cancer (24)
Management (13)
Manufacturing (21)
Medical device (2533)
Medtech (2534)
Mergers & acquisitions (2040)
Metabolic disorders (33)
Multiple sclerosis (12)
Neuroscience (532)
NextGen Class of 2024 (747)
Non-profit (564)
Northern California (125)
Obesity (12)
Opinion (36)
Parkinson's disease (14)
People (6976)
Phase I (1629)
Phase II (2624)
Phase III (2322)
Pipeline (47)
Postmarket research (203)
Preclinical (701)
Prostate cancer (16)
Radiopharmaceuticals (138)
Rare diseases (20)
Real estate (622)
Recruiting (17)
Regulatory (2284)
Research institute (408)
Resumes & cover letters (57)
Southern California (117)
Startups (365)
United States (1321)
Vaccines (154)
Date
Today (21)
Last 7 days (103)
Last 30 days (385)
Last 365 days (4228)
2024 (3838)
2023 (5003)
2022 (8744)
2021 (7453)
2020 (6079)
2019 (5868)
2018 (4400)
2017 (3873)
2016 (3821)
2015 (4382)
2014 (3313)
2013 (2864)
2012 (3014)
2011 (3207)
2010 (2800)
Location
Africa (98)
Arizona (25)
Asia (4916)
Australia (892)
California (280)
Canada (108)
China (15)
Colorado (18)
Europe (10972)
Florida (90)
Georgia (19)
Illinois (54)
Indiana (26)
Maryland (28)
Massachusetts (245)
Michigan (21)
Minnesota (34)
New Hampshire (13)
New Jersey (82)
New York (102)
North Carolina (45)
Northern California (125)
Ohio (15)
Pennsylvania (72)
South America (163)
Southern California (117)
Texas (71)
Washington State (26)
80,591 Results for "aspect imaging".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Aspect Imaging Celebrates First Installation of Embrace® Neonatal MRI System in Canada at The Hospital for Sick Children in Toronto
Aspect Imaging, the leading provider of compact MRI solutions, is proud to announce the successful installation of the Embrace® Neonatal MRI System at The Hospital for Sick Children in Toronto, Ontario, marking a significant milestone as the first installation of its kind in Canada.
March 28, 2024
·
2 min read
Drug Development
BrainStorm Cell Therapeutics Reaches Alignment with FDA on CMC Aspects of Phase 3b NurOwn® Clinical Trial
BrainStorm Cell Therapeutics Inc. ment with the U.S. Food and Drug Administration (FDA) on the Chemistry, Manufacturing, and Controls (CMC) aspects of Brainstorm’s Phase 3b clinical trial for NurOwn.
June 26, 2024
·
4 min read
Biotech Beach
Aspect Imaging Receives Innovative Technology Contract from Vizient for Embrace® Point of Care Neonatal MRI System
Aspect Imaging, LLC, the global leader in disruptive MRI systems for clinically complex neonatal patients announced its Embrace® Point of Care Neonatal MRI System has received an Innovative Technology contract from Vizient, Inc. the nation’s largest provider-driven healthcare performance improvement company.
September 20, 2023
·
3 min read
Press Releases
Neurocrine Biosciences Presents New KINECT®-HD Data Showing Consistent Efficacy Across 19 Subgroups and Improvements in Aspects of Emotional Health With INGREZZA® (valbenazine) Capsules
November 7, 2024
·
15 min read
Press Releases
Modular Medical Announces Issuance of U.S. Patent Covering Key Aspects of Core Pumping Technology
September 18, 2024
·
3 min read
Aspect Biosystems to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Aspect Biosystems today announced that Founder and CEO Tamer Mohamed will present at the 42nd Annual J.P. Morgan Healthcare Conference, held January 8-11, 2024 in San Francisco, CA.
January 4, 2024
·
1 min read
Press Releases
Radon Medical Imaging Announces Acquisition of Alpha Imaging
November 19, 2024
·
5 min read
Aspect Biosystems Named to Fast Company’s 2023 List of the Next Big Things in Tech
Aspect Biosystems announced that it has been named to Fast Company’s third annual Next Big Things in Tech list, honoring technological breakthroughs that promise to shape the future of industries — from healthcare and security to artificial intelligence and data.
November 28, 2023
·
2 min read
Press Releases
Aspect Biosystems Announces $200 Million Partnership with the Governments of Canada and British Columbia to Advance Development of Bioprinted Tissue Therapeutics
July 23, 2024
·
3 min read
Drug Development
Ocugen Gains FDA Alignment on Key Aspects of OCU400—Modifier Gene Therapy—Pivotal Phase 3 Study Design
Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN) today announced that the Company received alignment from FDA on key aspects of the Phase 3 clinical trial design to assess the safety and efficacy of OCU400 in patients with RHO and other gene mutations associated with Retinitis Pigmentosa (RP).
December 21, 2023
·
4 min read
1 of 8,060
Next
